Maria Tropp

Maria Tropp (Chvetchkova) has a strong background in regulatory affairs and labeling operations. Maria has held various leadership roles in global labeling for pharmaceutical companies such as Atara Biotherapeutics, The Janssen Pharmaceutical Companies of Johnson & Johnson, MyoKardia, Shire, Sanofi, Celgene, Pfizer, Bayer Healthcare, and Genzyme. Their experience includes developing and maintaining corporate, US, and EU labeling for various therapeutic areas, organizing and leading cross-functional expert teams, and presenting labeling updates for approval. Maria has also contributed to authoring SOPs, collecting competitive labeling intelligence, and providing support for inspection readiness activities. Maria Tropp has a particular expertise in oncological and hematological disorders.

Maria Tropp (Chvetchkova) has a diverse education history. Maria started their academic journey at Stony Brook University from 1997 to 2001, where they earned their Bachelor of Science degree in Psychology. Maria then pursued further education at Northeastern University in 2001, taking pre-requisite courses for the Dental Hygiene Program. In 2002, they attended the Massachusetts College of Pharmacy and Health Sciences, where they obtained a Post-Bachelor's Certificate in Dental Hygiene (RDH). Maria continued their studies at Simmons University from 2004 to 2006, specializing in Healthcare Administration and earning a Master's degree in Healthcare Administration (MHA).